Back to search

Article

Development of a novel glycoengineering platform for the rapid production of conjugate vaccines

2021-11-25

Abstract excerpt

Antimicrobial resistance (AMR) is threatening the lives of millions worldwide. Antibiotics which once saved countless lives, are now failing, ushering in vaccines development as a current global imperative. Conjugate vaccines produced either by chemical synthesis or biologically in Escherichia coli cells, have been demonstrated to be safe and efficacious in protection against several deadly bacterial diseases. Ho...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fa0bbe05-6adb-5ffd-aaa6-f7f6e205b686
DOI
10.1101/2021.11.25.470047
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of a novel glycoengineering platform for the rapid production of conjugate vaccinesDOI 10.1101/2021.11.25.470047
Development of a novel glycoengineering platform for the rapid production of conjugate vaccinesSemantic proximity
Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial VaccinesSemantic proximity
A scalable cell-free manufacturing platform for two-step bioproduction of immunogenic conjugate vaccinesSemantic proximity
Polysaccharide Conjugate Vaccines: From Historical Milestones to Future StrategiesSemantic proximity
A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in miceSemantic proximity
New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and GlueSemantic proximity
Mutation of M13 Bacteriophage Major Coat Protein for Increased Conjugation to Exogenous Compounds.Semantic proximity
Development of a Promising Bivalent Vaccine Against Klebsiella pneumoniae Based on Glycoengineered GMMA (geGMMA)Semantic proximity
Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against SARS-CoV-2 or pneumococcal infectionsSemantic proximity
Recombinant production platform for Group A Streptococcus glycoconjugate vaccinesSemantic proximity
A low-cost, thermostable, cell-free protein synthesis platform for on demand production of conjugate vaccinesSemantic proximity
Outer Membrane Vesicle Vaccine PlatformsSemantic proximity
Select a neighboring publication to make it the new centre.